SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI) -- Ignore unavailable to you. Want to Upgrade?

To: Extra Pale who wrote (313)6/25/2001 7:06:28 PM
From: Oak Tree  Respond to of 354
 
I love it -- I have far more NABI than anyone should have. So I finally can expect to get out of something with a profit. If it can keep going up for a while (and if I don't get too greedy) there is a chance I could have the resources I would need to live in the style I'd like to become acustomed to.



To: Extra Pale who wrote (313)6/25/2001 7:27:10 PM
From: Torben Noerup Nielsen  Respond to of 354
 
This is a good move for NABI. But note that they are now going from a profitable biotechnology company to a real biotechnology company.....

They shed the liability associated with human blood products and they get cash to fund their vaccine development. But they now have to make the vaccines work.

Once this divestiture is complete, they would appear to make a nice snack for a larger company with a vaccine businesss.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News